Join Dr. Gish, a leading expert in infectious diseases, as he delves into the complexities of Hepatitis B Virus (HBV) and the innovative "Treat All" approach. In this episode, Dr. Gish explores the 10 important reasons why we propose to treat all patient with HBV who are HBV DNA+

•         HBV DNA+ correlates with risk: risk of HCC, cirrhosis, liver transplant and death
•         Treatment decreases risk: 70% less HCC and 90% decrease in cirrhosis and liver transplant
•         Decrease Risk of Transmission  U=U
•         Treatment to prevent infection
•         Reduce Stigma
•         Improve QOL
•         Reduce HBV related extrahepatic disease
•         Decrease other HBV related cancers (bile duct cancer is an example)
•         Reduce Discrimination
•         Partner with Patients who request treatment

Listeners will gain insights into the importance of early diagnosis, the benefits of universal treatment, and the impact of Hepatitis B on global health. Whether you're a healthcare professional, a patient, or simply curious about liver health, this podcast offers valuable information and expert perspectives to empower and inform. Tune in to learn how we can work together to eliminate Hepatitis B!

As always, please share your comments or questions with Dr. Gish via email rgish@robertgish.com or via his website www.robertgish.com

Thank you for listening!